Log in to search using one of your social media accounts:

 

Hoth Therapeutics Inc. Announces Completion of Series A Financing
NEW YORK, Feb. 22, 2018 -- (Healthcare Sales & Marketing Network) -- Hoth Therapeutics Inc. ("Hoth" or the "Company"), a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from in... Biopharmaceuticals, Dermatology, Venture Capital Hoth Therapeutics, atopic dermatitis, eczema (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 22, 2018 Category: Pharmaceuticals Source Type: news

Kallyope Inc. Announces $66M Series B Financing to Advance Programs Targeting the Gut-Brain Axis
All existing backers including Lux Capital, The Column Group, and Polaris Partners joined by new investors Euclidean Capital and Two Sigma Ventures Progress in building a comprehensive map of gut-brain circuits and identification of therapeutic opportun... Biopharmaceuticals, Neurology, Venture Capital Kallyope, gut-brain axis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 22, 2018 Category: Pharmaceuticals Source Type: news

Mitralign raises $10m
Mitralign, which is looking to commercialize its namesake mitral valve treatment and pursue regulatory nods for its Trialign tricuspid valve device, said it raised nearly $10 million. The $9.8 million funding, of a hoped-for $30.2 million, came from 19 unnamed investors beginning last September, the Tewksbury, Mass.-based company said in a regulatory filing. Mitralign raised a $40 million Series E round in May 2016. The Mitralign and Trialign devices are designed to use wire and catheters to implant polyester anchors within the annulus of the mitral and tricuspid valves. The anchors are then cinched together...
Source: Mass Device - February 21, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Replacement Heart Valves Wall Street Beat Mitralign Inc. Source Type: news

Former Definity Health CEO's 'on-demand' insurance startup nabs $60M in venture capital
A health-benefits startup led by serial entrepreneur Tony Miller has closed a $60 million round of funding as it prepares to expand into new markets and ramp up hiring. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 20, 2018 Category: Pharmaceuticals Authors: Katharine Grayson Source Type: news

Merck and three partners start ExploreBio, a € 20 million pre-seed investment initiative in Israel
Merck, a leading science and technology company, today announced ExploreBio, a pre-seed-investment vehicle by four investment funds targeted at early-stage companies in the biotechnology landscape in Israel. For this purpose the strategic corporate venture capital arm of Merck has partnered with Arkin Holdings, Pontifax and WuXi AppTec to create the € 20 million pre-seed investment vehicle. (Source: World Pharma News)
Source: World Pharma News - February 20, 2018 Category: Pharmaceuticals Tags: Featured Merck Group Business and Industry Source Type: news

Blockchain Based Medical Device from NnBU Set to Raise €15million in ICO
New Neonatal Birth Unit is a World First to Improve Health Outcomes of Babies Born by C-Section NICOSIA, Cyprus, February 19, 2018 -- (Healthcare Sales & Marketing Network) --Today, Monday February 19 2018, NnBU Holdings Ltd (https://nnbu.io) announces... Devices, Venture Capital NnBU Holdings, blockchain, neonatal birth unit (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 19, 2018 Category: Pharmaceuticals Source Type: news

Perflow Medical Closes $12 Million in Financing to Treat Complex Neurovascular Disorders
Announces successful completion of over 50 commercial cases with the Stream™ Dynamic Neuro-Thrombectomy Net TEL AVIV, Israel, Feb. 15, 2018 -- (Healthcare Sales & Marketing Network) -- Perflow Medical, an Israeli-based medical device company that devel... Devices, Interventional, Neurology, Venture Capital Perflow Medical, CEREBRAL NET, Thrombectomy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 15, 2018 Category: Pharmaceuticals Source Type: news

1315 Capital raises $300M for second health care equity fund
Philadelphia venture capital firm 1315 Capital has closed its second health care growth equity fund at its hard cap of more than $300 million. The firm — which invests in commercial-stage specialty pharmaceutical, medical technology and healthcare services companies — had set a target of $250 million for the fund it is calling 1315 Capital II. Similar to the first fund, 1315 Capital II includes endowment, foundation, public and priv ate pension, and family office limited partners. “We appreciate… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 13, 2018 Category: Pharmaceuticals Authors: John George Source Type: news

1315 Capital raises $300M for second health care equity fund
Philadelphia venture capital firm 1315 Capital said Monday it closed its second health care growth equity fund at its hard cap of over $300 million. The firm — which invests in commercial-stage specialty pharmaceutical, medical technology and healthcare services companies — had set a target of $250 million for the fund it is calling 1315 Capital II. Similar to the first fund, 1315 Capital II includes endowment, foundation, public and priv ate pension, and family office limited partners. “We… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - February 12, 2018 Category: American Health Authors: John George Source Type: news

The Future of Medicine, From a Leader in Venture Capital The Future of Medicine, From a Leader in Venture Capital
The founder of Sun Microsystems predicted that artificial intelligence will replace 80% of physicians, but he says the profession could fortify itself by changing its focus.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 9, 2018 Category: Consumer Health News Tags: Internal Medicine Expert Interview Source Type: news

7D Surgical Completes Significant Round of Financing
Investment to fund commercialization and development of the game changing Machine-vision Image Guided Surgery (MvIGS) technology TORONTO, Feb. 6, 2018 -- (Healthcare Sales & Marketing Network) -- 7D Surgical is pleased to announce the completion of the... Devices, Surgery, Venture Capital 7D Surgical, MvIGS, Machine-vision, Image Guided Surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 6, 2018 Category: Pharmaceuticals Source Type: news

eNeura, Inc. Announces Series D Financing
Investment to fund commercialization of eNeura's sTMS mini for treatment and prevention of migraine BALTIMORE, Feb. 6, 2018 -- (Healthcare Sales & Marketing Network) -- eNeura, Inc., a privately held medical technology company developing non-invasive, ... Devices, Neurology, Venture Capital eNeura Inc, mini neuromodulation, SpringTMS, migraine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 6, 2018 Category: Pharmaceuticals Source Type: news

Partner Therapeutics, Inc. (PTx) Closes $60 Million Financing
Funds to support pipeline development and commercial operations BOSTON, Feb. 1, 2018 -- (Healthcare Sales & Marketing Network) -- Partner Therapeutics, Inc. (PTx) announced today the closing of a Series A financing to support the launch and growth of t... Biopharmaceuticals, Venture Capital Partner Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 1, 2018 Category: Pharmaceuticals Source Type: news

Long River Ventures rebrands as LRVHealth, launches $100m fund
Venture capital group Long River Ventures said today it is rebranding under the moniker LRVHealth and that it launched an early-stage digital health, medical device and diagnostics venture platform with a backing of $100 million in venture capital from its LRV IV investment fund. The venture platform is joined by more than 20 “well-known healthcare insiders and thought-leaders,” eight national healthcare systems and the Innovation Institute, LRV Health said. “LRVHealth has emerged as the premier early-stage healthcare venture capital firm. When the Innovation Institute began looking for a partner to launc...
Source: Mass Device - January 31, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Wall Street Beat lrvhealth Source Type: news

INSIGHTEC Closes $150 Million Series E Financing
HAIFA, Israel and MIAMI, January 31, 2018 -- (Healthcare Sales & Marketing Network) -- INSIGHTEC®, a commercial-stage medical technology company revolutionizing surgery with incisionless MRI-guided focused ultrasound (MRgFUS) announced today the closi... Devices, Venture Capital INSIGHTEC, MRgFUS, Exablate Neuro, essential tremor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 31, 2018 Category: Pharmaceuticals Source Type: news

Engine Biosciences Raises $10 Million in Seed Financing to Accelerate Drug Discovery Using Genomics and Artificial Intelligence
San Francisco- and Singapore-based biotech company raises $10 million in seed round from leading American and Asian investors; round was co-led by DHVC (Danhua Capital) and 6 Dimensions Capital, with participation from WuXi Apptec, EDBI, Pavilion Capital, ... Biopharmaceuticals, Venture Capital Engine Biosciences (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 31, 2018 Category: Pharmaceuticals Source Type: news

VC group MTVP raises $25m of $60m for medtech fund
Venture capital group Medical Technology Venture Partners has raised approximately $24.8 million for a medtech-focused fund, according to recently posted SEC filing. The fund is looking to raise an additional approximate $35.3 million, with the first contribution to the fund noted on March 24, 2017, according to the SEC filing. The venture group reportedly looks to fund and support medical technology entrepreneurs, claiming to have overseen the “conception, development, and launch of over 30 medical devices and diagnostic products,” according to its website. The fund is partnered with the University of Californ...
Source: Mass Device - January 29, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Wall Street Beat Medical Technology Venture Partners Source Type: news

Flow Neuroscience Raises 1.1M USD in Seed Round Lead by Khosla Ventures to Develop a Device to Treat Depression
STOCKHOLM, January 26, 2018 -- (Healthcare Sales & Marketing Network) -- Flow Neuroscience, a Sweden-based medtech company is developing a new treatment for depression combining brain stimulation with behavioral therapy. They have now secured a $1.1 milli... Devices, Neurology, Venture Capital Flow Neuroscience, Major Depressive Disorder, neuromodulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 26, 2018 Category: Pharmaceuticals Source Type: news

Baltimore startup Protenus raises $11 million
Baltimore health data security company, Protenus, has raised  an $11 million Series B round of financing, co-led by Kaiser Permanente Ventures and F-Prime Capital Partners. Arthur Ventures, Lionbird Venture Capital, and Cognosante Ventures also participated in the most recent fundraise. This round follows the raise of a $3 million extension last year on the company's $4 million Series A round. Protenus, founded in 2014, utilizes artificial intelligence technology to help hospitals and health systems… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 24, 2018 Category: Pharmaceuticals Authors: Morgan Eichensehr Source Type: news

Baltimore startup Protenus raises $11 million
Baltimore health data security company, Protenus, has raised  an $11 million Series B round of financing, co-led by Kaiser Permanente Ventures and F-Prime Capital Partners. Arthur Ventures, Lionbird Venture Capital, and Cognosante Ventures also participated in the most recent fundraise. This round follows the raise of a $3 million extension last year on the company's $4 million Series A round. Protenus, founded in 2014, utilizes artificial intelligence technology to help hospitals and health systems… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 24, 2018 Category: Biotechnology Authors: Morgan Eichensehr Source Type: news

Philips joins $9m round for remote-care co LindaCare
Digital health company LindaCare has landed an $8.7 million Series B round, with investments made by Philips (NYSE:PHG), PMV, Capricorn ICT Arkiv, Connecticut Innovations and others. The Belgium-based company said it plans to use the newly-acquired funds to accelerate its U.S. market expansion and product commercialization, as well as build out its existing patient monitoring software platform for a broader range of cardiac diseases. “This investment is a significant step for us, as it enables LindaCare to execute faster on our ambitious vision and strategy, and to take a leading market position across both...
Source: Mass Device - January 24, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Funding Roundup Patient Monitoring lindacare royalphilips Source Type: news

Neuspera Medical Announces Initial Close of $26M Series B Equity Financing
Global Healthcare Investor 6 Dimensions Capital Leads Round SAN JOSE, Calif., Jan. 24, 2018 -- (Healthcare Sales & Marketing Network) -- Neuspera Medical Inc., a clinical stage, private venture capital backed neuromodulation company, today announced th... Devices, Neurology, Venture Capital, Personnel Neuspera Medical, neuromodulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 24, 2018 Category: Pharmaceuticals Source Type: news

Neuspera Medical raises $26m Series B for injectable neuromod device
Neuspera Medical said today that it raised a $26 million Series B round for the injectable neuromodulation devices it’s developing. Formerly known as Vivonda Medical, San Jose, Calif.-based Neuspera said the round was led by 6 Dimensions Capital, joined by all of its Series A investors, including Action Potential Venture Capital and Windham Venture Partners, and new backers Delta Capital and Purple Arch Ventures. Neuspera said it plans to use the cash for product development and clinical programs. “Neuspera powered implants may lead to earlier adoption of neuromodulation based treatment therapies due ...
Source: Mass Device - January 24, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Neuromodulation/Neurostimulation Wall Street Beat NeuSpera Medical Source Type: news

Skyhawk Therapeutics Launches With $8 Million in Seed Financing to Advance Its Novel Platform and Portfolio of Small Molecules That Correct RNA Expression
The company's founders are leading experts in the development of small molecule therapeutics for RNA-driven disease. Skyhawk's initial pipeline is focused on neurological and cancer indications WALTHAM, Mass., Jan. 23, 2018 -- (Healthcare Sales & Market... Biopharmaceuticals, Venture Capital, Personnel Skyhawk Therapeutics, RNA expression (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 23, 2018 Category: Pharmaceuticals Source Type: news

These medtech companies raised the most VC last year
[Image from unsplash.com]Perhaps there’s a ray of hope that venture capital funding is recovering a bit for the medical device industry. VC firms invested more than $2.8 billion in 2017, an increase of more than $647 million from 2016, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There were a total 229 deals involving medical device companies last year. The companies raking in the VC cash are doing everything from creating robotic microsurgery for the eyes to building better dialysis machines to bringing neuromodulation to bear on epilepsy. Read on to discover which medtech com...
Source: Mass Device - January 19, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Cardiovascular Funding Roundup Hospital Care Implants mHealth (Mobile Health) Advanced Cardiac Therapeutics Inc. Auris Surgical Robotics Cereve EarLens Ebb Therapeutics EBR Systems Inc. Fractyl Laboratories immusant MedTech Mox Source Type: news

The CareVoice gets $2M to bring its cost, quality transparency app to China
The CareVoice, a Shanghai, China-based digital health startup targeting the insurance market, has raised $2 million in early-stage funding. Haitao Capital and SOSV, two China- and US-based venture capital firms, led the round. Other Chinese and Southeast Asian investors also contributed. (Source: mobihealthnews)
Source: mobihealthnews - January 18, 2018 Category: Information Technology Source Type: news

Global digital health venture capital funding up 42 per cent at $7.2 billion
The total corporate funding for Healthcare IT companies - including debt and public market financing - climbed to $8.2 billion in 2017, 47% increase from the $5.6 billion raised in 2016. (Source: The Economic Times)
Source: The Economic Times - January 18, 2018 Category: Consumer Health News Source Type: news

ShangPharma Innovation partners with Icahn School of Medicine
Venture capital firm ShangPharma Innovation Inc. is teaming up with the Icahn School of Medicine at Mount Sinai  (ISMMS) to accelerate the development of early-stage therapeutics. As part of the multi-year strategic collaboration, ShangPharma pledges to provide multiple years of R&D funding at ISMMS ’s clinical institutes in New York. The goal, according to a prepared statement released Tuesday, is to further ISMMS’s objectives of validating drug targets and establishing programs to discover… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 16, 2018 Category: Pharmaceuticals Authors: Anthony Noto Source Type: news

McKesson Ventures Donates $10,000 to Alzheimer ’s Association
SAN FRANCISCO – January 16, 2018 – McKesson Ventures, the venture capital arm of McKesson Corporation, today announced that it has donated $10,000 to the Alzheimer’s Association on behalf of its former portfolio company ClearCare, the market leading SaaS and mobile platform for home care agencies. S... (Source: McKesson News)
Source: McKesson News - January 16, 2018 Category: Information Technology Source Type: news

Google venture arm backs universal flu vaccine clinical trial
A U.K. company developing what it hopes will be a universal flu vaccine has raised $27 million US from investors including GV, the venture capital arm of Google parent Alphabet Inc. (Source: CBC | Health)
Source: CBC | Health - January 15, 2018 Category: Consumer Health News Tags: News/Health Source Type: news

Initial round of investors on board for developing universal flu vaccine
A U.K. company developing what it hopes will be a universal flu vaccine has raised $27 million US from investors including GV, the venture capital arm of Google parent Alphabet Inc. (Source: CBC | Health)
Source: CBC | Health - January 15, 2018 Category: Consumer Health News Tags: News/Health Source Type: news

Google venture arm backs UK universal flu vaccine company
LONDON (Reuters) - A private British company developing a vaccine that would be the first in the world to fight all types of flu has raised 20 million pounds ($27 million) from investors including GV, the venture capital arm of Google parent Alphabet Inc. (Source: Reuters: Health)
Source: Reuters: Health - January 15, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Truffle Capital drums up $102m for French medtech startups
Truffle Capital said this week that the initial closing of its new venture fund, Truffle BioMedTech, brought in $102 million (€85 million) of a hoped-for $240 million. Led by European and Asian institutional and corporate investors and family offices, the fund will look to sniff out “major breakthroughs” at North American and European research centers and spin them out as up to 12 startups in France, Truffle said. “As a major European venture capital player in the fields of interventional medicine, connected bioprostheses and biotechnology, Truffle Capital attracts prominent investors, scientist...
Source: Mass Device - January 12, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Wall Street Beat trufflecapital Source Type: news

Report: Q3 2017 Healthcare VC funding steady, digital health deals drop
Venture Capital funding in the healthcare sector during the third quarter of 2017 stayed mostly in line with the previous quarter while digital health deals saw a significant drop, according to a PricewaterhouseCoopers and CB Insights MoneyTree report. VC funding during the third quarter of 2017 was directly in line with the previous quarter, but still down 6% when compared to the same quarter last year. The healthcare sector netted a total of $3.2 billion invested through 171 deals, according to the report, comprising 13% of the total VC funding for the quarter. Those numbers are down slightly from the previous quarter wh...
Source: Mass Device - January 10, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Wall Street Beat Auris Surgical Robotics CB Insights PricewaterhouseCoopers (PwC) Source Type: news

ClearLine MD(TM) Secures $5.5MM Funding for Commercialization of ClearLine IV(TM)
WOBURN, Mass., Jan. 9, 2018 -- (Healthcare Sales & Marketing Network) -- ClearLine MD, a medical device company focused on reducing the impact of iatrogenic Air Burden to patients and improving the safety and effectiveness of intravenous (IV) therapy, tod... Devices, Venture Capital ClearLine MD, ClearLine, iatrogenic Air, intravenous (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 9, 2018 Category: Pharmaceuticals Source Type: news

Venture capital invests big in Tampa metro companies in 2017
Venture funding helps companies expand their operations, often adding high-wage and high-skill jobs and fueling economic growth and development in the area. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 9, 2018 Category: Health Management Authors: Margie Manning Source Type: news

Venture capital-backed Zyga Technology sold to Florida firm
Venture capital-backed med-tech company Zyga Technology Inc. has reached a deal to be sold to RTI Surgical Inc. for an undisclosed amount. Zyga sells tools physicians use to treat sacroiliac joint dysfunction, a condition that can cause chronic pain, especially in the lower back. The company’s products help stabilize joints that connect the hip and spine, preventing them from rubbing together and causing pain. Bob Assell, a former executive at medical-device maker TranS1 Inc., launched Zyga in… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 8, 2018 Category: Health Management Authors: Katharine Grayson Source Type: news

Intuity Medical Obtains $70M in Funding From Existing Investors and Hercules Capital
Financing will fund the commercial launch of Intuity Medical's POGO® Automatic™ Blood Glucose Monitoring System, the first fully-integrated blood glucose monitor FREMONT, Calif., Jan. 8, 2018 -- (Healthcare Sales & Marketing Network) -- Intuity Med... Diagnostics, Monitoring, Endocrinology, Venture Capital Intuity Medical, POGO , Blood Glucose Monitor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 8, 2018 Category: Pharmaceuticals Source Type: news

STORM Therapeutics Extends Series A Round to Include New Investor Taiho Ventures
Taiho Ventures First Investment in Europe CAMBRIDGE, England, January 8, 2018 -- (Healthcare Sales & Marketing Network) -- STORM Therapeutics, the leading drug discovery company focused on small molecule therapies modulating RNA modifying enzymes, toda... Biopharmaceuticals, Venture Capital, Personnel STORM Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 8, 2018 Category: Pharmaceuticals Source Type: news

Genome Medical Expands Financing with Strategic Investments by GE Ventures, Kaiser Permanente Ventures and Illumina Ventures
The First National Medical Practice Focused on Genomics Has Now Raised More Than $23 Million in Financing to Improve Access to Genetic Services SAN FRANCISCO, Jan. 5, 2018 -- (Healthcare Sales & Marketing Network) -- Genome Medical today announced a Se... Diagnostics, Venture Capital Genome Medical, genomics medical practice (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 5, 2018 Category: Pharmaceuticals Source Type: news

Miracor closes $30m Series D
Miracor Medical Systems said today it closed a $30.2 million (EU €25 million) round of funding as part of Series D financing round with funds slated to support further development and commercialization of its PiCSO impulse system, and announced it is moving its headquarters from Austria to Belgium. The company’s PiCSO therapy is designed to be used during stenting procedures for patients affected by acute myocardial infarcts to improve pressure in the coronary venous system to improve microcirculatory flow and improve perfusion in the infarcted area. The round was led by Shenzhen, China-based Ming Capital and co...
Source: Mass Device - January 4, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Miracor Source Type: news

Neurogastrx, Inc. Raises $45M Series A To Bring Lead GI Candidate Through Proof Of Concept
JIM O'MARA NAMED CHIEF EXECUTIVE OFFICER BOSTON, Jan. 4, 2018 -- (Healthcare Sales & Marketing Network) -- Neurogastrx, Inc., a private biopharmaceutical company focused on discovering and developing therapies for gastrointestinal disorders affecting t... Biopharmaceuticals, Venture Capital, Personnel Neurogastrx, Gastroparesis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 4, 2018 Category: Pharmaceuticals Source Type: news

Personal Genome Diagnostics Raises $75 Million to Bring Regulated IVD Genomic Tests to Cancer Patients Worldwide
Series B Financing Co-led by Bristol-Myers Squibb and New Enterprise Associates BALTIMORE, Jan. 4, 2018 -- (Healthcare Sales & Marketing Network) -- Personal Genome Diagnostics Inc. (PGDx) today announced a $75 million Series B financing co-led by new ... Diagnostics, Oncology, Venture Capital Personal Genome Diagnostics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 4, 2018 Category: Pharmaceuticals Source Type: news

Oculis Raises CHF20 Million in a Series B Financing Round to Advance Breakthrough Treatments for Ophthalmic Diseases
New Investors include Bay City Capital, Novartis Venture Fund and Pivotal bioVenture Partners LAUSANNE, Switzerland, January 4, 2018 -- (Healthcare Sales & Marketing Network) -- Oculis (www.oculis.com), a clinical-stage biotechnology company focused on... Biopharmaceuticals, Ophthalmology, Venture Capital Oculis , Diabetic Macular Edema (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 4, 2018 Category: Pharmaceuticals Source Type: news

Enterome Raises €32 Million ($38.5 Million) in a Series D Financing
Proceeds will be used to progress lead development programs - EB8018 for IBD and EO2315 for cancer Secures €40 million loan facility ($48 million) from the European Investment Bank PARIS and CAMBRIDGE, Massachusetts, January 4, 2018 -- (Healthcare Sa... Biopharmaceuticals, Venture Capital Enterome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 4, 2018 Category: Pharmaceuticals Source Type: news

Chicago startup raises $1M to connect OCD patients with doctors
A Chicago-based app aimed at treating obsessive-compulsive disorder just got a helpful boost from a local healthcare venture capital firm. nOCD, a mobile mental health app that uses cognitive behavioral therapy techniques to assist in treating OCD patients, has received $1 million from 7wire Ventures, a Chicago-based healthcare venture fund. The funding will go toward scaling up the app’s development team, which will help build t he upcoming patient-clinician interface in the app, said Northbrook,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 27, 2017 Category: Biotechnology Authors: Tatiana Walk-Morris Source Type: news

Biotech VC scorecard: How the state's biggest firms fared in 2017
The biotech sector experienced a resurgence in 2017, with IPOs, drug approvals and industry stocks up nationwide. So it ought to come as no surprise that the state ’s biggest healthcare-focused venture capital firms had a productive year. Flagship Pioneering, Third Rock Ventures, Polaris Partners and Atlas Venture combined to launch 11 biotech startups headquartered in Massachusetts in 2017, while seeing seven local portfolio companies go public and unveili ng a handful of new funds. That performance… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 26, 2017 Category: Pharmaceuticals Authors: Max Stendahl Source Type: news

Biotech VC scorecard: How the state's biggest firms fared in 2017
The biotech sector experienced a resurgence in 2017, with IPOs, drug approvals and industry stocks up nationwide. So it ought to come as no surprise that the state ’s biggest healthcare-focused venture capital firms had a productive year. Flagship Pioneering, Third Rock Ventures, Polaris Partners and Atlas Venture combined to launch 11 biotech startups headquartered in Massachusetts in 2017, while seeing seven local portfolio companies go public and unveili ng a handful of new funds. That performance… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 26, 2017 Category: Biotechnology Authors: Max Stendahl Source Type: news

Year in Review: See the top funding deals for Phoenix tech-focused companies during 2017
It was a big year for local tech companies as they collectively raised tens of millions of dollars to expand their companies and hire. About $10 million was the magic number for several fast-growing startups as they each found prominent venture capital firms to give them a fresh funding injection to move forward. In March, Gilbert-based student financial aid engagement software startup CampusLogic raised $10 million in a Series B round. In June, Microsoft Ventures led a $10 million Series B… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 26, 2017 Category: Pharmaceuticals Authors: Hayley Ringle Source Type: news